Membership
Tour
Register
Log in
Oasis Pharmaceuticals, LLC
Follow
Organization
Lexington, MA, US
Organizations
Overview
Industries
People
People
Information
Transactions
Events
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Protease-activated receptor-2 modulators
Patent number
11,732,027
Issue date
Aug 22, 2023
Oasis Pharmaceuticals, LLC
Richard J. Looby
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Protease-activated receptor-2 modulators
Patent number
11,091,533
Issue date
Aug 17, 2021
Oasis Pharmaceuticals, LLC
Richard Looby
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Please log in for detailed analytics
Patents Applications
last 30 patents
Information
Patent Application
PROTEASE-ACTIVATED RECEPTOR-2 MODULATORS
Publication number
20210061883
Publication date
Mar 4, 2021
Oasis Pharmaceuticals, LLC
Richard J. Looby
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PROTEASE-ACTIVATED RECEPTOR-2 MODULATORS
Publication number
20170137492
Publication date
May 18, 2017
Oasis Pharmaceuticals, LLC
Richard Looby
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
NIH Research Project
last 12 months
processing...
Count: 15
Research Projects
Information
Research Project
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke The...
Application id
10325956
Award notice date
Aug 31, 2021
Information
Research Project
PAR2 Pepducins as a Novel Treatment of Idiopathic Pulmonary Fibrosis
Application id
9906265
Award notice date
Apr 2, 2020
Information
Research Project
Development of PAR2 Pepducins as a Novel NASH Treatment
Application id
9771446
Award notice date
Aug 29, 2019
Information
Research Project
PAR2 Pepducins as a Novel Treatment of Idiopathic Pulmonary Fibrosis
Application id
9711028
Award notice date
Apr 3, 2019
Information
Research Project
Development of PAR2 Pepducins as a Novel NASH Treatment
Application id
9565559
Award notice date
Aug 28, 2018
Information
Research Project
PAR2 Pepducins as a Novel Treatment of Idiopathic Pulmonary Fibrosis
Application id
9558198
Award notice date
May 18, 2018
Information
Research Project
Development of PAR2 Pepducins as a Novel NASH Treatment
Application id
9408141
Award notice date
Sep 14, 2017
Information
Research Project
Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis
Application id
9335790
Award notice date
Aug 18, 2017
Information
Research Project
Development of PAR4 Pepducins as a Novel Antithrombotic Treatment
Application id
9254228
Award notice date
Apr 30, 2017
Information
Research Project
Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis
Application id
9285016
Award notice date
Aug 22, 2016
Information
Research Project
Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis
Application id
8979343
Award notice date
Aug 26, 2015
Information
Research Project
Supplement to grant 5R42DK101240 Oasis Pharmaceuticals to attend BI...
Application id
9066456
Award notice date
Jun 5, 2015
Information
Research Project
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic st...
Application id
8849906
Award notice date
Mar 31, 2015
Information
Research Project
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic st...
Application id
8781807
Award notice date
May 16, 2014
Information
Research Project
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic st...
Application id
8648560
Award notice date
Sep 20, 2013